tiprankstipranks
Marizyme Announces Director Julie Kampf’s Resignation
Company Announcements

Marizyme Announces Director Julie Kampf’s Resignation

Marizyme Incorporated (MRZM) has released an update to notify the public and investors about its officers.

Julie Kampf has resigned from her position on the board of directors of Marizyme, Inc., effective January 31, 2024, coinciding with the expiration of her independent director agreement. Her departure is not due to any disputes or disagreements with the company’s operations, policies, or practices.

For further insights into MRZM corporate activity, check out TipRanks’ Insiders Trading Activity page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TipRanks Auto-Generated NewsdeskMarizyme Inc. Wins FDA Nod for DuraGraft Storage Advancement
GlobeNewswireMarizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!